Lenalidomide capsules.
Active Awarded
- Contract number
- 36C26026F0124
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,534,077
Award facts
- Contract value 100% obligated
- $2,534,076.50 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 20 awarded a $2.53 million firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide capsules. This delivery order, issued on January 16, 2026, with a completion date of January 15, 2027, represents a continuation of Exelan's extensive pharmaceutical supply relationship with the VA healthcare system. The contract contains no set-aside designation, allowing full and open competition. Exelan, a foreign-owned pharmaceutical manufacturer and distributor headquartered in Boca Raton, Florida, will perform work at its primary facility with delivery to Cary, North Carolina. Lenalidomide is a critical immunomodulatory medication used in the treatment of oncologic and hematologic malignancies across the VA's network of facilities.
This delivery order operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), leveraging an established procurement framework that enables efficient acquisition of pharmaceutical products across federal agencies. Exelan maintains a substantial portfolio of indefinite delivery contracts with the VA National Acquisition Center and Defense Logistics Agency, with existing single-award IDCs for Lenalidomide products valued up to $21.17 million through Veterans Integrated Service Network 22, along with numerous other pharmaceutical products serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The company operates primarily as a prime contractor without major subcontractors, positioning it as a long-term strategic supplier within the federal pharmaceutical procurement landscape.
Quick answers
Who was awarded contract 36C26026F0124?
36C26026F0124 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 16, 2026.
How much is contract 36C26026F0124 worth?
The government has obligated $2,534,077 on 36C26026F0124.
Is contract 36C26026F0124 an order under another contract?
Yes. 36C26026F0124 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0124 competed?
The extent of competition for 36C26026F0124 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award